10 High Growth Stocks Insiders Are Buying
Insider buying tends to get attention because it signals that company executives are putting personal capital behind their own businesses.
Outlook Therapeutics Inc. (OTLK)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Armistice Capital Steven Boyd | 4,168,000 | $857,774 | 0.02% | |
| 2. | Renaissance Technologies Jim Simons | 255,157 | $52,511 | 0% | |
| 3. | Connective Capital Management Rob Romero | 200,000 | $41,160 | 0.03% | |
| 4. | 113,700 | $23,399 | -7% | 0% | |
| 5. | 80,800 | $16,629 | -92% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.83 | 29,000 | $24,145.40 | 66,167 | 2026-06-02 | Filing | |
| $0.59 | 8,539,709 | $4,999,999.62 | 22,092,068 | 2026-05-28 | Filing | |
| $0.41 | 122,174 | $50,005.82 | 125,574 | 2026-05-27 | Filing | |
| $0.44 | 34,000 | $14,960.00 | 37,167 | 2026-05-26 | Filing | |
| $0.43 | 5,000 | $2,145.00 | 5,593 | 2026-05-26 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.14 | 520,000 | $590,200.00 | 653,058 | 2023-04-20 | Filing | |
| $1.11 | 267,000 | $296,370.00 | 745,975 | 2023-01-20 | Filing | |
| $1.22 | 103,255 | $125,971.10 | 1,012,975 | 2023-01-19 | Filing | |
| $1.25 | 33,738 | $42,172.50 | 1,116,230 | 2023-01-18 | Filing | |
| $1.31 | 27,162 | $35,582.22 | 1,149,968 | 2023-01-17 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 20,000 | $31,800 | 0.01% | |
| 2. | 15,000 | $23,850 | 0% | |
| 3. | 3,000 | $4,770 | 0% |
News See All
Outlook Therapeutics, Inc. (NASDAQ:OTLK) Q3 2024 Earnings Call Transcript
Operator: Greetings. And welcome to the Outlook Therapeutics Corporate Third Quarter Fiscal Year 2024 Update Conference Call and Webcast. At this time, all participants are in a listen-only mode.
Top 10 Holdings of Caligan Partners
Founded in 2017, Caligan Partners is one of the most significant specialty hedge funds.
Outlook Therapeutics, Inc. (NASDAQ:OTLK) Q2 2024 Earnings Call Transcript
Operator: Hello, and welcome to the Outlook Therapeutics Inaugural Quarterly Update Conference Call and Webcast. As a brief reminder all participants are currently in a listen-only mode.
Insiders are Piling into These 10 Healthcare Stocks in 2024
In this article, we will take a detailed look at Insiders are Piling into These 10 Healthcare Stocks in 2024. For a quick overview of such stocks, read our article Insiders are Piling into These 5 ...
5 Stocks Receiving a Massive Vote of Approval From Wall Street Analysts
In this article, we discuss the 5 stocks receiving a massive vote of approval from Wall Street analysts.
12 Best Day Trading Stocks To Buy
Over the past few years, the rise of a new generation of stock traders that like to engage in risky bets, coupled with the advent of stock trading mobile applications, has given increased popularity to...
Hedge Fund and Insider Trading News: BlueCrest Capital Management, Haidar Capital Management, Tiger Global Management, Three Arrows Capital, Biohaven Pharmaceutical Holding Co Ltd (BHVN), Braze, Inc. (BRZE), and More
Few hedge fund managers have exploited the retreat from quantitative easing as spectacularly as Said Haidar.
5 Unknown Biotech Stocks That Can Explode in 2022
In this article, we discuss the 5 unknown biotech stocks that can explode in 2022.
11 Best Penny Stocks To Buy According To Hedge Funds
In this article, we discuss the 11 best penny stocks to buy according to hedge funds.
Hedge Fund Resource Center